Chemfab Alkalis Q1 FY27: Revenue ₹73.16 Cr, PAT ₹7.51 Cr
Q1 FY27 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹73Cr
- −20.1% YoY
- −2.2% QoQ
- Net profit
- ₹6Cr
- +124.7% YoY
- +1093.8% QoQ
- Margin
- 13.85%
- +1.5 pp YoY
- +2.5 pp QoQ
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Chemfab Alkalis Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Consolidated Q1FY27 Revenue from Operations: ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). Quarterly EBITDA (Q1FY27, Consolidated): ₹10.13 crore - Year-on-year (Y-o-Y) change: -10.35% (from ₹11.30 crore in Q1FY26) - Operating EBITDA margin: 13.85% (up 150 bps Y-o-Y from 12.34%)
From Chemfab Alkalis Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Consolidated Q1FY27 Revenue from Operations: ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). (Page 7)
- Chemical Segment Q1FY27 Revenue: ₹67.41 crore, up 27.57% YoY (from ₹52.84 crore in Q1FY26). (Page 8)
- OPVC Segment Q1FY27 Revenue: ₹5.75 crore, down 85.14% YoY (from ₹38.70 crore in Q1FY26). (Page 9)
- ECU Realisations in Chlor-Alkali: Improved sequentially to ₹39,600/MT from ₹39,100/MT in Q4FY26 (Page 6, Page 5)
2 more points from Chemfab Alkalis Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Chemfab Alkalis Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Chlor-Alkali business:
- ₹56 crore invested in technology modernisation to improve power efficiency by July 2025 (completed Q3FY26).
- ₹15 crore invested in a 10 MW hybrid power project reducing power cost; supply started Q1 FY27 (operational from 25th May 2026).
- OPVC Pipes Business capacity expansion at Sri City:
- Scaling from 14,000 TPA (FY25) to 20,000 TPA (FY26) with new production lines.
- Additional lines planned: 5th line (Q2FY26, ₹27 crore), 6th line (Q3FY26, ₹28 crore), 7th line (Q2FY27, ₹30 crore).
- Total capex for lines 5-7 approximately ₹85 crore.
- Each line capacity: 2,500-3,000 TPA; payback ~2–2.5 years.
2 more points from Chemfab Alkalis Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Chemfab Alkalis Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Chemfab Alkalis Ltd said on order book & pipeline — free account, 30 seconds.
Chemfab Alkalis Ltd — Quarterly revenue & net profit
Chemfab Alkalis Ltd Q1 FY27 results — key figures
| ₹ Cr | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 73 | 92 | -20.1% | 75 | -2.2% |
| Operating profit (EBITDA) | 10 | 11 | -10.4% | 9 | +18.9% |
| Operating margin | 13.85% | 12.34% | +1.5 pp | 11.39% | +2.5 pp |
| Profit before tax | 2 | 5 | -52.8% | 1 | +80.5% |
| Net profit (PAT) | 6 | 3 | +124.7% | 0 | +1093.8% |
| EPS (₹) | 3.99 | 1.78 | +124.2% | 0.33 | +1109.1% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹76 Cr, net loss ₹2 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Chemfab Alkalis's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Chemfab Alkalis Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Chemfab Alkalis Ltd Q1 FY27 results?
Consolidated Q1FY27 Revenue from Operations: ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). Quarterly EBITDA (Q1FY27, Consolidated): ₹10.13 crore - Year-on-year (Y-o-Y) change: -10.35% (from ₹11.30 crore in Q1FY26) - Operating EBITDA margin: 13.85% (up 150 bps Y-o-Y from 12.34%)
What is Chemfab Alkalis Ltd share price analysis?
Chemfab Alkalis Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹531 Cr. Investors should review the full earnings analysis for detailed insights.
Is Chemfab Alkalis Ltd planning capital expenditure?
Chlor-Alkali business: - ₹56 crore invested in technology modernisation to improve power efficiency by July 2025 (completed Q3FY26).
Keep Chemfab Alkalis Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
